Trial intelligence / Profile preview

Prophylactic oral dextrose gel dose-finding trial for neonatal hypoglycaemia prevention

ACTRN12613000322730Phase 3Completed

Sponsor
The University of Auckland
Start
Aug 2013
Countries
1
01

Overview

Phase 3, randomised trial of dextrose in Neonatal hypoglycemia (8 arms), sponsored by The University of Auckland. Primary endpoint: Incidence of neonatal hypoglycaemia. Started Aug 2013; status: completed.

02

Drugs

dextrose
03

Conditions

Neonatal hypoglycemia

Beyond the preview

Go deeper on ACTRN12613000322730.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000322730.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call